Testosterone Phenylpropionate 100mg/ml

Testosterone Phenylpropionate 100mg/ml is a fast-acting injectable androgen and anabolic steroid (AAS), commonly used in hormone replacement therapy (HRT) and performance enhancement.

As an esterified variant of testosterone, its phenylpropionate side chain determines its pharmacokinetic profile—distinct from longer esters like cypionate or enanthate.

At a concentration of 100mg per milliliter, this formulation offers moderate potency and predictable release.

The phenylpropionate ester has a half-life of approximately 4–5 days, requiring injections every 2–3 days to maintain stable serum testosterone levels.

This frequent dosing contrasts with longer esters (weekly injections) but provides quicker saturation and clearance, making it useful for users who need rapid adjustments or shorter cycles.

Medically, Testosterone Phenylpropionate is prescribed for hypogonadism, delayed puberty, or certain breast cancer cases in women.

A typical HRT dose ranges from 50–100mg every 4–5 days, titrated based on serum levels and symptom relief. Compared to longer esters, it allows faster dose fine-tuning and reduces the risk of prolonged suppression of natural testosterone production upon discontinuation.

Its rapid action suits short-term cycles (6–8 weeks) or use as a “front-loading” compound alongside slower esters. Common dosages range from 300–500mg weekly, divided into two or three injections.

As with all testosterone esters, risks include suppression of the hypothalamic-pituitary-gonadal (HPG) axis, requiring post-cycle therapy (PCT) with SERMs like tamoxifen or clomiphene.

From a clinical standpoint, the 100mg/ml concentration is less common than higher concentrations (e.g., 200mg/ml or 250mg/ml), meaning more injection volume for equivalent doses, which may increase local post-injection pain or irritation.